Carla L. Esposito

Naples, 80146, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 50 publications

Advances in Aptamer Diagnostics Targeting Non-Small-Cell Lung Cancer: A Systematic Review.

Advances in Aptamer Diagnostics Targeting Non-Small-Cell Lung Cancer: A Systematic Review.

Journal: International journal of molecular sciences

Published: June 26, 2026

Unraveling the NMR structures of G-quadruplex-forming aptamers acting as inhibitors of High Mobility Group Box 1 (HMGB1) pathological activity.

Unraveling the NMR structures of G-quadruplex-forming aptamers acting as inhibitors of High Mobility Group Box 1 (HMGB1) pathological activity.

Journal: International journal of biological macromolecules

Published: December 30, 2025

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients.

Proof-of-concept study of clinical use of blood-based MAVS biosensor in predicting immunotherapy response in SCLC patients.

Journal: Translational oncology

Published: October 14, 2025

FMR1 RNA interaction with DNMT1 blocks DNA methylation at the FMR1 locus.

FMR1 RNA interaction with DNMT1 blocks DNA methylation at the FMR1 locus.

Journal: NAR molecular medicine

Published: September 09, 2025

Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation.

Aptamer-based applications in delivering cancer gene therapies and beyond: state of the art and the missing links to clinical translation.

Journal: Advanced drug delivery reviews

Published: April 11, 2025

The chimeric aptamer axl-miR-214sponge inhibits breast cancer and melanoma dissemination.

The chimeric aptamer axl-miR-214sponge inhibits breast cancer and melanoma dissemination.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: October 27, 2024

Ex.50.T aptamer impairs tumor-stroma cross-talk in breast cancer by targeting gremlin-1.

Ex.50.T aptamer impairs tumor-stroma cross-talk in breast cancer by targeting gremlin-1.

Journal: Cell death discovery

Published: May 21, 2024

Bi-functional CpG-STAT3 decoy oligonucleotide triggers multilineage differentiation of acute myeloid leukemia in mice.

Bi-functional CpG-STAT3 decoy oligonucleotide triggers multilineage differentiation of acute myeloid leukemia in mice.

Journal: Molecular therapy. Nucleic acids

Published: February 09, 2024

Directing in Vitro Selection towards G-quadruplex-forming Aptamers to Inhibit HMGB1 Pathological Activity.

Directing in Vitro Selection towards G-quadruplex-forming Aptamers to Inhibit HMGB1 Pathological Activity.

Journal: Angewandte Chemie (International ed. in English)

Published: January 12, 2024

The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses.

The Small RNA Landscape in NSCLC: Current Therapeutic Applications and Progresses.

Journal: International journal of molecular sciences

Published: February 28, 2023

Selection of RNA aptamers targeting hypoxia in cancer.

Selection of RNA aptamers targeting hypoxia in cancer.

Journal: Frontiers in molecular biosciences

Published: May 30, 2022

STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts.

STAT3 silencing by an aptamer-based strategy hampers the crosstalk between NSCLC cells and cancer-associated fibroblasts.

Journal: Molecular therapy. Nucleic acids

Published: May 12, 2022

Showing 1-12 of 50

Last Updated: 09/26/2026